Related Experiment Video
Updated: Jul 14, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
The Runx3 distal transcript encodes an additional transcriptional activation domain
David D Chung1, Kazuho Honda, Lorraine Cafuir
1Center for Cell Signaling and Department of Biochemistry, and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Runx3, a key regulator of T-cell development, has an alternative N-terminal domain that enhances CD8(+) T-cell function. This domain is crucial for CD8(+) T-cell activation and expansion, impacting immune responses.
Area of Science:
- Immunology
- Molecular Biology
- Developmental Biology
Background:
- Runx3 is a transcriptional regulator vital for CD8(+) T-cell development and function.
- Runx3 expression is upregulated during CD8(+) T-cell differentiation and in peripheral CD8(+) T cells.
- Targeted deletions in Runx3 lead to significant defects in CD8(+) T-cell development and activation.
Purpose of the Study:
- To investigate the role of alternative N-terminal sequences of Runx3 in CD8(+) T-cell function.
- To characterize the expression patterns and functional significance of different Runx3 isoforms.
- To understand the contribution of the distal promoter-driven Runx3 isoform to T-cell activity.
Main Methods:
- Analysis of Runx3 expression during T-cell differentiation and activation.
- Generation and analysis of mice with targeted deletions in Runx3.
- Functional assays to assess the transcriptional activity of Runx3 isoforms.
Main Results:
- Runx3 transcripts from the distal promoter are selectively expressed in mature, activated CD8(+) T cells.
- The longer N-terminal region of Runx3, encoded by distal promoter transcripts, contains an independent transcriptional activation domain.
- This domain enhances transcriptional activity compared to isoforms from the proximal promoter.
- Defects in Runx3 lead to reduced CD8(+) T-cell numbers and impaired effector cell expansion.
Conclusions:
- The alternative N-terminal activation domain of Runx3 plays a critical role in CD8(+) T-cell function.
- Selective expression of this domain in mature and activated CD8(+) T cells highlights its importance in adaptive immunity.
- Understanding Runx3 isoforms provides insights into T-cell development and potential therapeutic targets.
More Related Videos
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
06:02A Computational Pipeline for Intergenic/Intragenic Enhancer RNA Quantification in Mouse Embryonic Stem Cells
Published on: October 28, 2025
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
Inheritance of Chromatin Structures
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors